Healthcare
Cellceutix Corporation , a biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant cancers, announced that its recent research has shown that its flagship anticancer compound ...
10 minutes ago
Pharmspective, LLC today announced the release of its second syndicated report - Molecular Diagnostics Insights in Oncology. This new extensive survey of over 400 oncologists characterizes the emerging molecular diagnostics landscape and the role ...
17 minutes ago
Synageva BioPharma Corp. , a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, will present at the Jefferies 2012 Global Health Care Conference being held in New York City.
22 minutes ago
New innovation in smoking cessation provides 60 second craving relief.
23 minutes ago
Auxilium Pharmaceuticals, Inc. today announced that executive management will participate in the Goldman Sachs Global Healthcare Conference 2012 to be held June 5-7, 2012 at Terranea in Rancho Palos Verdes, CA. Mr. Adrian Adams, Chief Executive ...
24 minutes ago
Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
24 minutes ago
Isis Pharmaceuticals, Inc. , the leader in antisense therapeutics, today announced that management will present a company overview at the Goldman Sachs 33rd Annual Global Healthcare Conference on Tuesday, June 5, 2012 at 1:20 p.m. PT at the ...
24 minutes ago
For Rachel Fikes marketing has never been about the sale, but about the customer, a philosophy that's proven measurable with Rising's revenue growth increasing nearly fivefold during her tenure. Now the Company is looking to bring its customer-...
24 minutes ago
Xalkori Now Available in Canada
24 minutes ago
Teleflex Incorporated announced today the Arrow FlexTip Plus Closed Tip, Multi-Port epidural catheter has received 510 clearance from the U.S. Food and Drug Administration .
25 minutes ago
HealthHelp announced today its major-level sponsorship of Institute 2012. America's Health Insurance Plans' annual conference for health insurance decision makers will take place June 20 through 22 at the Calvin L. Rampton Salt Palace Convention ...
25 minutes ago
Amedisys, Inc. , one of America's leading home health and hospice companies, today announced that William F. Borne, Chief Executive Officer and Ronald A. LaBorde, President and Chief Financial Officer will present at the Jefferies 2012 Global ...
25 minutes ago
Repligen Corporation today announced that Walter C. Herlihy, Ph.D., President and Chief Executive Officer, will present a corporate update at the Jefferies 2012 Global Healthcare Conference in New York. The Repligen presentation is scheduled for ...
25 minutes ago
Acorda Therapeutics, Inc. , makers of Ampyra , today announced the launch of Ampyra Dialogues, the first-ever online talk show where patients and medical experts talk about how walking problems affect people living with MS. The first edition of ...
25 minutes ago
Seegene Inc. , a leading developer of multiplex molecular diagnostic technologies and tests, today announced the development of a new molecular technology that for the first time allows high multiplexing and multiple quantification from a single ...
25 minutes ago
Foundation Medicine announced today the commercial launch of FoundationOne , the first pan-cancer, fully informative genomic profile designed to help oncologists expand their patients' treatment options. FoundationOne is optimized to fit current ...
55 minutes ago
AVEO Oncology today announced that the AVEO management team will host a conference call on Monday, June 4, 2012 at 7:30 a.m. to review the Phase 3 TIVO-1 data that will be presented at the 2012 Annual Meeting of the American Society of Clinical ...
55 minutes ago
Comfort Zone® Products Kicks Off Summer Early With Comfort Zone Cool Cat Sweepstakes; Grand Prize Is A Pet-Friendly Vacation
61 minutes ago
Exelixis, Inc. today announced that it has completed the filing of its rolling New Drug Application with the U.S. Food and Drug Administration for cabozantinib as a treatment for patients with progressive, unresectable, locally advanced, or ...
83 minutes ago
Exelixis, Inc. today announced the initiation of COMET-1, a phase 3 pivotal trial of cabozantinib in men with metastatic castration-resistant prostate cancer . The primary endpoint for COMET-1 is overall survival in mCRPC patients who have had ...
83 minutes ago
1 - 20 of 139099 Stories
<<
<
Next 20 Healthcare
>
>>
Search News
